BOSTON -- I'm ready for summer to be over. It hasn't been a particularly restful period, not with credit crunches fueling crazy market volatility. The biotech sector -- my little corner of Wall Street -- has held up OK, but the summer months don't generate much news or investor interest.
I've circled Sept. 4 on my calendar, the day after Labor Day, as the day when investors get back to work and make the big push to the end of the year. Fall is a peppy time for biotech stocks, too. The summer doldrums fade in a flurry of investor conferences, medical meetings and stock-moving catalysts.
I want to be prepared for the fall rush, and I want you to be ready too. Below, I've gathered together all the information (lists of clinical trials, FDA decision dates, medical conference calendars) that, hopefully, gets you out of summer sloth mode and puts your brain back in gear. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,309.92 | 1,091.49 | 2,138.44 | 32.31 |
Oil *
77.12
|
|
DOWN
154.48
|
DOWN
19.14
|
DOWN
37.61
|
DOWN
0.48
|
10 Yr
3.23%
SPDR Gold
115.06
|
|
-1.48%
|
-1.72%
|
-1.73%
|
-1.46%
|
Data delayed 20 minutes |
Connect with TheStreet